DelMar Pharmaceuticals announces pricing of $6.8 million underwritten public offering
DelMar announced pricing of an underwritten public offering of 6,750,000 shares of its common stock and warrants to purchase up to an aggregate of 6,750,000 shares of common stock. Each share is being sold together with one warrant at a combined price of $1.00 per share. August 14, 2019
